Bio-Rad Laboratories (BIO.B) vs Edwards Lifesciences (EW)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Bio-Rad Laboratories (BIO.B) has outperformed Edwards Lifesciences (EW) over the past year, gaining 28.2% versus a gain of 11.8%. Over five years, EW leads with a -23.5% price change compared with -50.5% for BIO.B. Edwards Lifesciences is the larger company by market cap ($49.44 billion vs $9.76 billion), about 5.1 times the size.
On valuation, Bio-Rad Laboratories trades at a lower trailing P/E (46.3x vs 51.1x for Edwards Lifesciences). Bio-Rad Laboratories converts more of its revenue into profit, with a net margin of 29.4% versus 17.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BIO.B | EW |
|---|---|---|
| Share price | $365.08 | $85.78 |
| Market cap | $9.76B | $49.44B |
| 1-day change | 0.00% | -0.81% |
| YTD return | +17.50% | +0.62% |
| 1-year return | +28.15% | +11.81% |
| 5-year return | -50.54% | -23.52% |
| P/E ratio (TTM) | 46.27 | 51.06 |
| Forward P/E | — | 25.40 |
| EPS (TTM) | $7.89 | $1.68 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.58B | $6.07B |
| Revenue growth (YoY) | +0.65% | +11.55% |
| Net income (latest FY) | $759.90M | $1.07B |
| Gross margin | 51.87% | 78.01% |
| Operating margin | 1.83% | 20.84% |
| Net margin | 29.42% | 17.69% |
| 52-week high | $365.08 | $96.29 |
| 52-week low | $244.54 | $72.30 |
| Distance from 52-week high | 0.00% | -10.91% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +18.86% |
| Average volume | 6 | 3.82M |
| Shares outstanding | 5.06M | 576.40M |
| Employees | 7,450 | 16,000 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Edwards Lifesciences is about 5.1 times larger than Bio-Rad Laboratories by market value ($49.44B vs $9.76B).
- BIO.B has outperformed EW by 16.3 percentage points over the past year.
- Bio-Rad Laboratories is more profitable, keeping 29.4 cents of every revenue dollar as net income versus 17.7 cents for Edwards Lifesciences.
- Edwards Lifesciences grew revenue faster in its latest fiscal year (+11.55% vs +0.65%).
About Bio-Rad Laboratories
BIO.B stock →Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.
Healthcare · Medical Devices · 7,450 employees
About Edwards Lifesciences
EW stock →Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands.
Healthcare · Medical Devices · 16,000 employees
BIO.B vs EW FAQ
Which is bigger, Bio-Rad Laboratories or Edwards Lifesciences?
Edwards Lifesciences (EW) is larger, with a market capitalization of $49.44B compared with $9.76B for Bio-Rad Laboratories (BIO.B).
Which stock has performed better over the past year, BIO.B or EW?
BIO.B returned +28.15% over the past 12 months, compared with +11.81% for EW (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, BIO.B or EW?
BIO.B has the lower trailing P/E at 46.3, versus 51.1 for EW. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Bio-Rad Laboratories and Edwards Lifesciences in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.